Priebe Waldemar

10% OwnerCNS Pharmaceuticals, Inc. (CNSP) · full profile →Form 4 · filed Aug 1, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$133K
Net Open-Market Flow
-$133K
Transactions
17
17 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2023Sell(S)10K$1.04$10K157K
Mar 27, 2023Sell(S)5K$1.09$5K167K
Mar 24, 2023Sell(S)5K$1.08$5K172K
Mar 23, 2023Sell(S)10K$1.08$11K177K
Mar 22, 2023Sell(S)5K$1.08$5K187K
Mar 21, 2023Sell(S)5K$1.10$6K192K
Mar 20, 2023Sell(S)5K$1.08$5K197K
Mar 17, 2023Sell(S)5K$1.13$6K202K
Mar 16, 2023Sell(S)5K$1.24$6K207K
Mar 15, 2023Sell(S)5K$1.22$6K212K
Mar 14, 2023Sell(S)5K$1.35$7K217K
Mar 13, 2023Sell(S)5K$1.30$7K222K
Mar 10, 2023Sell(S)5K$1.29$6K227K
Dec 9, 2022Sell(S)3K$2.43$7K232K
Dec 8, 2022Sell(S)6K$2.40$13K235K
Dec 7, 2022Sell(S)6K$2.46$14K240K
Dec 6, 2022Sell(S)6K$2.47$14K246K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-23-001044) within minutes of acceptance. Every field above traces to the original document. Verify it directly: